With the soaring popularity of drugs like Ozempic, the market is ripe for disruption,” researcher Rubina Aktar said.

Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea in obese adults ...

There’s a reason it’s so hard to keep weight off — and it has nothing to do with your diet or how often you exercise .

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 ...

HEALTH chiefs have spent £91,000 on two life-size obese dolls — to train nurses and paramedics in dealing with the growing ...

Elected officials are looking to expand access to weight loss drugs like Ozempic and Wegovy for low-income Virginians as part ...

Walking speed can provide insights into health, extending beyond mere mobility, so much so that it is considered to be the ...

T he weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by ...

Based on the findings, it’s difficult to draw a definitive conclusion that eating late actually causes diabetes or will make ...

Up to half of obstructive sleep apnea patients taking Zepbound had no symptoms after one year of treatment, averaging 25 ...